Frédéric Troalen
About
In The Last Decade
Frédéric Troalen
35 papers receiving 973 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 429
- Radiology, Nuclear Medicine and Imaging 316
- Immunology 307
- Reproductive Medicine 299
- Public Health, Environmental and Occupational Health 131
Countries citing papers authored by Frédéric Troalen
This map shows the geographic impact of Frédéric Troalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Troalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Troalen more than expected).
Fields of papers citing papers by Frédéric Troalen
This network shows the impact of papers produced by Frédéric Troalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Troalen. The network helps show where Frédéric Troalen may publish in the future.
Co-authorship network of co-authors of Frédéric Troalen
This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Troalen. A scholar is included among the top collaborators of Frédéric Troalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Troalen. Frédéric Troalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 17 | |
| 3 | 23 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 12 | |
| 7 | 34 | |
| 8 | 5 | |
| 9 | 17 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 7 | |
| 13 | 6 | |
| 14 | Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. | 162 |
| 15 | 26 | |
| 16 | 32 | |
| 17 | 26 | |
| 18 | 28 | |
| 19 | 182 | |
| 20 | [Monoclonal antibodies directed against the beta hCG subunit and against a synthetic peptide analog of the carboxyl-terminal end. Clinical use in vivo and in vitro]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.